39.14

0.52% -0.18

Pennant Group Inc (PNTG)

Overview News Price History Option Chain Financials Discussions Forecast

Pennant Group Inc stock is traded at $39.14, with a volume of 131.34K. It is down -0.52% in the last 24 hours and down -6.76% over the past month. Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

Previous Close:

$39.32

Open:

$39.57

24h Volume:

131.34K

Relative Volume:

0.46

Market Cap:

$1.37B

Revenue:

$1.02B

Net Income/Loss:

$35.54M

P/E Ratio:

45.80

EPS:

0.8546

Net Cash Flow:

$40.81M

1W Performance:

-1.32%

1M Performance:

-6.76%

6M Performance:

+22.81%

1Y Performance:

+54.85%

1-Day Range:

$38.51

$39.57

1-Week Range:

$37.96

$40.55

52-Week Range:

$22.25

$42.69

Pennant Group Inc Stock (PNTG) Company Profile

Name

Pennant Group Inc

Sector

Healthcare (1089)

Industry

Medical Care Facilities (48)

Phone

(208) 401-1400

Address

1675 E. RIVERSIDE DRIVE, EAGLE, ID

Employee

9,700

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

PNTG's Discussions on Twitter

Compare PNTG vs HCA, THC, FMS, EHC, DVA

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PNTG Pennant Group Inc	39.10	1.37B	1.02B	35.54M	40.81M	0.8546
HCA Hca Healthcare Inc	406.98	87.61B	76.39B	7.81B	7.93B	29.08
THC Tenet Healthcare Corp	265.94	21.57B	21.46B	2.65B	3.35B	19.23
FMS Fresenius Medical Care Ag Adr	23.54	12.65B	22.44B	1.35B	2.03B	1.9002
EHC Encompass Health Corp	121.95	12.19B	6.07B	793.80M	464.40M	5.9914
DVA Davita Inc	176.88	11.49B	13.84B	1.10B	1.49B	10.42

Pennant Group Inc Stock (PNTG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-08-25	Initiated	William Blair	Outperform
Dec-02-25	Upgrade	Truist	Hold → Buy
Nov-18-25	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-24-25	Initiated	Jefferies	Buy
Dec-19-24	Initiated	Wells Fargo	Equal Weight
Jan-05-24	Upgrade	Stephens	Equal-Weight → Overweight
Feb-27-23	Upgrade	Stifel	Hold → Buy
Aug-25-22	Initiated	Oppenheimer	Outperform
Jun-21-22	Downgrade	Stephens	Overweight → Equal-Weight
Mar-01-22	Downgrade	Stifel	Buy → Hold
Sep-21-21	Initiated	Stifel	Buy
Jun-10-21	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Jul-21-20	Initiated	Stephens	Overweight
Jan-15-20	Initiated	SunTrust	Hold
Oct-22-19	Initiated	RBC Capital Mkts	Sector Perform

View All

Pennant Group Inc Stock (PNTG) Latest News

Aug 16, 2026

Pennant group CEO Brent Guerisoli sells $165,066 in shares By Investing.com - Investing.com South Africa

Aug 16, 2026

Pennant group chief clinical officer sells $53,699 in stock By Investing.com - Investing.com Australia

Aug 16, 2026

Will Pennant’s Higher 2026 Guidance and Tucson Acquisition Change Pennant Group's (PNTG) Narrative - simplywall.st

Aug 14, 2026

Aug 12, 2026

How (PNTG) Movements Inform Risk Allocation Models - Stock Traders Daily

Aug 12, 2026

Wasatch Advisors LP Raises Position in The Pennant Group, Inc. $PNTG - marketbeat.com

Aug 12, 2026

Renaissance Technologies LLC Decreases Stock Position in The Pennant Group, Inc. $PNTG - marketbeat.com

Aug 12, 2026

Aug 11, 2026

Wells Fargo & Company Raises The Pennant Group (NASDAQ:PNTG) Price Target to $46.00 - marketbeat.com

Aug 11, 2026

Wells Fargo raises Pennant Group stock price target on earnings outlook - Investing.com Nigeria

Aug 11, 2026

The Pennant Group, Inc. (PNTG) Stock Analysis: A 16.46% Upside In The Healthcare Sector - DirectorsTalk Interviews

Aug 11, 2026

Aug 10, 2026

Pennant Group Chief Clinical Officer Jason Paul Steik sells 1,394 shares for $53,700.67 - Bitget

Aug 10, 2026

Pennant Group CEO Brent Guerisoli Sells 4,285 Shares Under Rule 10b5-1 Plan - Kalkine Media

Aug 10, 2026

Pennant Group EVP Kirk Sterling Cheney Sells 1,393 Shares Under 10b5-1 Trading Plan - Kalkine Media

Aug 10, 2026

Pennant Group (PNTG) EVP & GC sells 1,393 shares via Rule 10b5-1 plan - Stock Titan

Aug 10, 2026

Pennant Group (PNTG) CEO executes 4,285-share planned stock sale at $38.52 - Stock Titan

Aug 10, 2026

Pennant Group (PNTG) Chief Clinical Officer sells 1,394 shares in Rule 10b5-1 trade - Stock Titan

Aug 10, 2026